Liminatus Pharma, Inc.
LIMN
$6.15
-$0.15-2.38%
NASDAQ
| 12/31/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 56.00K | 26.00K | 434.00K | ||
| Total Receivables | 3.67M | 1.65M | 945.00K | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 156.00K | 40.00K | 22.00K | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 1.40M | 876.00K | 840.00K | ||
| Total Current Assets | 5.28M | 2.59M | 2.24M | ||
|
|
|||||
| Total Current Assets | 5.28M | 2.59M | 2.24M | ||
| Net Property, Plant & Equipment | 1.00K | 1.00K | 1.00K | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 126.00K | -- | -- | ||
| Total Assets | 5.41M | 2.59M | 2.24M | ||
|
|
|||||
| Total Accounts Payable | 1.48M | 939.00K | 933.00K | ||
| Total Accrued Expenses | 3.10M | 1.75M | 858.00K | ||
| Short-term Debt | 19.97M | 17.25M | 16.05M | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | 195.00K | 197.00K | 195.00K | ||
| Total Other Current Liabilities | 195.00K | 197.00K | 195.00K | ||
| Total Current Liabilities | 24.75M | 20.14M | 18.04M | ||
|
|
|||||
| Total Current Liabilities | 24.75M | 20.14M | 18.04M | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | 19.97M | 17.25M | 16.05M | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 24.75M | 20.14M | 18.04M | ||
|
|
|||||
| Common Stock & APIC | 9.33M | 9.33M | 9.33M | ||
| Retained Earnings | -28.67M | -26.87M | -25.12M | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -19.34M | -17.55M | -15.79M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -19.34M | -17.55M | -15.79M | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -19.34M | -17.55M | -15.79M | ||
|
|
|||||